版本:
中国

BRIEF-Roche says first phase III data on tecentriq to feature at the ESMO Congress

Oct 3 Roche Holding Ag

* Roche media release: first phase III data on Roche's TECENTRIQ (atezolizumab) to feature at the 2016 European Society for Medical Oncology (ESMO) Congress Source text for Eikon: [here ] Further company coverage: (Reporting By Zurich newsroom)

更多 瑞士市场报道

热门文章

编辑推荐

文章推荐